The transdermal patch and the vaginal ring: two novel methods of combined hormonal contraception
Swica, Y.
Obstetrics and Gynecology Clinics of North America 34(1): 31-42 Viii
2007
ISSN/ISBN: 0889-8545 PMID: 17472863 DOI: 10.1016/j.ogc.2007.01.005Document Number: 665875
This article reviews two novel contraceptive methods that have become recently available in the United States: the transdermal patch and the vaginal ring. In general, newer methods of contraception are designed to make adherence easier for patients. The two contraceptive methods discussed in this article may help patients achieve this goal.
Document emailed within 0-6 h
Related Documents
Craig, A.D.; Steinauer, J.; Kuppermann, M.; Schmittdiel, J.A.; Dehlendorf, C. 2019: Pill, patch or ring? a mixed methods analysis of provider counseling about combined hormonal contraception Contraception 99(2): 104-110Lopez, L.M.; Grimes, D.A.; Gallo, M.F.; Schulz, K.F. 2008: Skin patch and vaginal ring versus combined oral contraceptives for contraception Cochrane Database of Systematic Reviews 1: Cd003552
van Vliet, H.A.A.M.; Rosendaal, F.R.; Fleischer, K.; Rosing, J.; Helmerhorst, F.M. 2010: Effects of the contraceptive vaginal ring, the contraceptive transdermal patch and combined oral contraceptives on markers of hemostasis Contraception 81(1): 88-9; author reply 89-90
Meyer, S. 2009: Contraceptive patch and vaginal ring vs. combined oral contraceptives American Family Physician 80(3): 232
Vasilev, D. 1991: Contraception via a vaginal hormonal ring Akusherstvo i Ginekologiia 30(1): 49-52
Kalogirou, D.; Antoniou, G.; Karakitsos, P.; Kalogirou, O.; Antoniou, D.; Giannikos, L. 1996: A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response International Journal of Fertility and Menopausal Studies 41(6): 522-527
Agarwal, N.; Gupta, M.; Kriplani, A.; Bhatla, N.; Singh, N. 2016: Comparison of combined hormonal vaginal ring with ultralow-dose combined oral contraceptive pills in the management of heavy menstrual bleeding: a pilot study Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 36(1): 71-75
Gaspard, U. 2003: Le médicament du mois : Evra® : premier patch pour la contraception transdermique - Evra® : First transdermal patch for contraception Rmlg. Revue Medicale de Liege 58(11): 709-712
Ahrén, T.; Lithell, H.; Victor, A.; Vessby, B.; Johansson, E.D. 1981: Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring. II. Serum lipoproteins and apolipoproteins Contraception 24(4): 451-468
Bakhshani, N.M.; Hosseinbor, M.; Shahraki, Z.; Sakhavar, N. 2013: Premenstrual syndrome symptomatology among married women of fertile age based on methods of contraception (hormonal versus non-hormonal methods of contraception) Global Journal of Health Science 6(2): 105-111
Bakhshani, N.M.; Hosseinbor, M.; Shahraki, Z.; Sakhavar, N. 2013: Premenstrual syndrome symptomatology among married women of fertile age based on methods of contraception (hormonal versus non-hormonal methods of contraception) Global Journal of Health Science 6(2): 105-111
Saldanha, N. 2018: Use of Short Acting Reversible Contraception in Adolescents: the Pill, Patch, Ring and Emergency Contraception Current Problems in Pediatric and Adolescent Health Care 48(12): 333-344
Camacho, D.P.; Consolaro, M.ár.E.L.; Patussi, E.V.ér.; Donatti, L.él.; Gasparetto, A.é; Svidzinski, T.I.E. 2007: Vaginal yeast adherence to the combined contraceptive vaginal ring (CCVR) Contraception 76(6): 439-443
Law, A.; Lee, Y.-C.; Gorritz, M.; Plouffe, L. 2014: Does switching contraceptive from oral to a patch or vaginal ring change the likelihood of timely prescription refill? Contraception 90(2): 188-194
Kerns, J.; Darney, P. 2011: Vaginal ring contraception Contraception 83(2): 107-115
Jensen, J.T.; Archer, D.F.; Westhoff, C.L.; Nelson, A.L.; Graham, S.; Bernick, B. 2023: Satisfaction with a Segesterone Acetate and Ethinyl Estradiol Contraceptive Vaginal System Among Recent Oral Contraceptive or Hormonal Contraceptive Vaginal Ring Users Journal of Women's Health 32(7): 808-815
Zhang, C.; Li, H.; Xiong, X.; Zhai, S.; Wei, Y.; Zhang, S.; Zhang, Y.; Xu, L.; Liu, L. 2017: An open-label, two-period comparative study on pharmacokinetics and safety of a combined ethinylestradiol/gestodene transdermal contraceptive patch Drug Design Development and Therapy 11: 725-731
2013: Thrombotic risk of contraceptive transdermal patches and the contraceptive vaginal ring Prescrire International 22(143): 266 268-9
Black, A.; Guilbert, E.; Costescu, D.; Dunn, S.; Fisher, W.; Kives, S.; Mirosh, M.; Norman, W.V.; Pymar, H.; Reid, R.; Roy, Gève.; Varto, H.; Waddington, A.; Wagner, M-Soleil.; Whelan, A.Marie. 2017: No. 329-Canadian Contraception Consensus Part 4 of 4 Chapter 9: Combined Hormonal Contraception Journal of Obstetrics and Gynaecology Canada: Jogc 39(4): 229-268.E5
Jensen, J.T. 2013: Vaginal ring delivery of selective progesterone receptor modulators for contraception Contraception 87(3): 314-318